Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Tarimo, Edith A M ^a,b   Thorson, Anna ^a   Kohi, Thecla W ^b   Bakari, Muhammad ^b   Mhalu, Fred ^b   Kulane, Asli ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DRUG EFFECT; DRUG SAFETY; FAMILY ATTITUDE; FEAR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; PEER GROUP; REFUSAL TO PARTICIPATE; REPRODUCTIVE HEALTH; TANZANIA; VACCINATION; VACCINATION REACTION; ALGORITHM; EPIDEMIOLOGY; HUMAN EXPERIMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS; TREATMENT REFUSAL;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; AIDS VACCINES; ALGORITHMS; CAUSALITY; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; FEMALE; HIV INFECTIONS; HUMAN EXPERIMENTATION; HUMANS; INTERVIEWS AS TOPIC; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFUSAL TO PARTICIPATE; TANZANIA; TREATMENT REFUSAL; YOUNG ADULT;

EID: 79951874130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014619     Document Type: Article

References (25)

1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
2. Brown-Peterside P, Chiasson MA, Ren L, Koblin BA, (2000) Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City. J Urban Health 77: 425-437.
3. Brown-Peterside P, Rivera E, Lucy D, Slaughter I, Ren L, et al. (2001) Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE. Am J Public Health 91: 1377-1379.
4. Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, et al. (2004) Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 36: 604-612.
5. de Bruyn G, Hudgens MG, Sullivan PS, Duerr AC, (2005) Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr 39: 499-501.
6. Harro CD, Judson FN, Gorse GJ, Mayer KH, Kostman JR, et al. (2004) Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 37: 1385-1392.
7. Mills E, Cooper C, Guyatt G, Gilchrist A, Rachlis B, et al. (2004) Barriers to participating in an HIV vaccine trial: a systematic review. Aids 18: 2235-2242.
8. Newman PA, Duan N, Roberts KJ, Seiden D, Rudy ET, et al. (2006) HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr 41: 210-217.
9. Newman PA, Duan N, Rudy ET, Anton PA, (2004) Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come? AIDS Patient Care STDS 18: 691-701.
10. Rudy ET, Newman PA, Duan N, Kelly EM, Roberts KJ, et al. (2005) HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake. AIDS Educ Prev 17: 253-267.
11. McGrath JW, George K, Svilar G, Ihler E, Mafigiri D, et al. (2001) Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr 27: 381-388.
12. Mills E, Nixon S, Singh S, Dolma S, Nayyar A, et al. (2006) Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge. PLoS Med 3: e94.
13. Tarimo EAM, Thorson A, Kohi TW, Mwami J, Bakari M, et al. (2010) Balancing Collective Responsibility, Individual Opportunities and Risks: A Qualitative Study on how Police Officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania. BMC Public Health 10: 292.
14. Newman PA, Daley A, Halpenny R, Loutfy M, (2008) Community heroes or "high-risk" pariahs? Reasons for declining to enroll in an HIV vaccine trial. Vaccine 26: 1091-1097.
15. Esparza J, Osmanov S, Pattou-Markovic C, Toure C, Chang ML, et al. (2002) Past, present and future of HIV vaccine trials in developing countries. Vaccine 20: 1897-1898.
16. International AIDS Vaccine Initiative (2009) Database of AIDS Vaccine Candidate in Clinical Trials. Available: http://www.iavireport.org/trials-db/Pages/default.aspx.
17. UNAIDS (2009) AIDS epidemic update. Geneva.
18. SAAVI (2009) HIV Vaccine Info-line 080 VACCINE. Cape Town.
19. Graneheim UH, Lundman B, (2004) Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 24: 105-112.
20. Tarimo EA, Thorson A, Bakari M, Mwami J, Sandstrom E, et al. (2009) Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania. Glob Health Action 2 DOI:10.3402/gha.v3402:3400.1953.
21. Patton MQ, (2002) Qualitative Research and Evaluation Methods. Thousands Oaks Sage Publications.
22. Ruzagira E, Wandiembe S, Bufumbo L, Levin J, Price MA, et al. (2009) Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health 14: 196-203.
23. Airhihenbuwa CO, (2007) Healing Our Differences: the Crisis of Global and the Politics of Identity. New York Rowman & Littlefield Publishers, Inc.
24. UNAIDS (2008) Sub-saharan Africa AIDS epidemic update, regional summary. Geneva UNAIDS and WHO.
25. Dahlgren L, Emmelin M, Winkvist A, (2007) Qualitative Methodology for International Public Health. Umea University Print och Media.